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Several advantages may derive from the use of dietary supplements containing multiple natural antioxidants and/or anti-
inflammatory agents. At present, however, there is scarce information on the properties and potential of combined supplements.
To fill the gap, the antioxidant and anti-inflammatory activities exerted by a combination of seven natural components (coenzyme
Q10, krill oil, lipoic acid, resveratrol, grape seed oil, 𝛼-tocopherol, and selenium) contained in a dietary supplement used for the
prevention of skin disorders were investigated in vitro. Each component was administered, alone or in combination, to human
keratinocytes, and the inhibition of Reactive Oxygen Species production and lipid peroxidation as well as the ability to reduce
inflammatory cytokine secretion and to modulate Nuclear Factor-𝜅B pathway was evaluated. The combination exhibited high
antioxidant activity and in specific conditions the combination’s efficiency was higher than that of the most powerful components
administered individually.Moreover, the combination showed remarkable anti-inflammatory properties. It reducedmore efficiently
than each component the secretion of Monocyte Chemoattractant Protein-1, a crucial cytokine for the development of chronic
inflammation in skin, and inhibited Nuclear Factor-𝜅B molecular pathway. Overall, our findings suggest that the combined
formulation may have the potential to powerfully inhibit oxidative stress and inflammation at skin level.
1. Introduction
The beneficial effects of natural compounds with antioxidant
and anti-inflammatory activities in the prevention of different
chronic pathologies have been studied for many years in
the laboratory where the present study was conducted [1–3].
Actually, the benefit resulting from a dietary supplementation
with these bioactive compounds once isolated from natural
sources is a quite controversial issue. Whereas most pre-
clinical and observational human studies demonstrated the
ability of these supplements to reduce the risk of several
chronic diseases, contrasting outcomes were obtained in
intervention human studies, and sometimes their use was
associated with an increased disease risk [4]. However, these
compounds are often supplemented at extremely high doses,
either in combination or individually, in capsules, pills,
tablets, powders, drinks, and so forth, and in these forms
theymay either induce prooxidant and cytotoxic effects [5] or
become extremely unstable. Conversely, it is known that the
natural combination of different intracellular antioxidants
(both enzymatic and nonenzymatic) ensures the reciprocal
protection against oxidative damage and instability and
induces synergic and interdependent effects [6]. Even though
a well-balanced diet may provide an adequate combination of
antioxidants [4] and prevent pathologies associated to oxida-
tive stress, the dietary supplementation with formulations
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combining several compounds with known antioxidant/anti-
inflammatory effects may represent an interesting and alter-
native strategy for disease prevention, especially in those
regions where vegetables and other dietary sources are not
easily available at reasonable prices or in acceptable amounts
to satisfy the requirements of the general population. More-
over, these combined formulations could be very useful in
those subjects that, due to health problems, either cannot
ingest/adsorb foods at high content of antioxidants or show a
high “oxidative status” [7], like sport-people or individuals
predisposed to chronic diseases pathogenically related to
oxidative stress and inflammation.
It was previously shown by us that synthetic molecules
composed of two antioxidant substances molecularly con-
jugated exerted higher antioxidant effect than the parental
compounds [2, 8]. Some of these antioxidant substances were
also included by us in lipid nanoparticles, whose basal struc-
ture was constituted by another antioxidant compound, with
the aim to transport and protect them [9]. Dietary supple-
ments containing combinations of natural antioxidant/anti-
inflammatory compounds can be presently found in the
market.They are largely publicized for their powerful healthy
effects, even though the available information on their pro-
perties is quite scarce [10], being dietary supplements not
required to go through testing like drugs. Thus, it appears
crucial to understand if such combinations are balanced,
efficacious, and more powerful in preventing oxidation/
inflammation than each of their bioactive components. To
this aim, in the present work, the effect in vitro of one of
these dietary supplements composed of a combination of
seven components with known antioxidant and/or anti-
inflammatory properties (coenzyme Q10 (CQ10), krill oil
(KO), lipoic acid (LA), resveratrol (Resv), grape seed oil
(GO), 𝛼-tocopherol (𝛼-T), and Na-selenite (Se)) was studied.
This dietary supplement is recommended for the prevention
of skin disorders that are pathogenically related to both
oxidative stress and inflammation. Each single component
was administered alone or in different combinations to two
human immortalized keratinocyte lines (NCTC 2544 and
HaCaT) showing different degrees of differentiation [11, 12],
and the antioxidant activity and the ability to inhibit the
inflammatory response were evaluated. Overall, the findings
obtained suggest that the combined treatment has the poten-
tial to provide additional benefits in the prevention of chronic
diseases showing an oxidative and/or inflammatory patho-
genesis. The possibility of a topical use of a formulation con-
taining the combination of the compounds/oils examined has
been also suggested.
2. Materials and Methods
2.1. Cell Lines. HaCaT human immortalized keratinocytes
were obtained from American Type Culture Collection
(ATCC, Rockville, MD, USA), and NCTC 2544 human
immortalized keratinocytes were kindly gifted by Dr. R. De
Bellis (Universita` degli Studi di Urbino, Urbino, Italy). As
previously demonstrated [11, 12], these two cell lines show
a different degree of differentiation and express cytokine
patterns typical of either less differentiated basal layers of
epidermis (NCTC 2544) or more differentiated superficial
layers of epidermis (HaCaT). Both cell lines were cultured
in DMEMmedium containing glutamine (2mM), antibiotics
(100 U/mL penicillin and 100 𝜇g/mL streptomycin), and 10%
FBS in a humidified atmosphere at 37∘C and 5% CO
2
. Cells
were maintained in an exponential growth rate by subcultur-
ing them at the density of 3 × 105 cells/mL twice a week. Cell
viability was analyzed through the Trypan blue dye exclusion
method.
2.2. Supplement Components and Concentrations Used. The
antioxidant and anti-inflammatory activities of the following
compounds/oils included in the formulation of a dietary sup-
plement were evaluated: coenzymeQ10, L.C.M. Trading SpA,
Milan, Italy; krill oil, Aker Biomarine Antarctic AS, Oslo,
Norway; lipoic acid, Giellepi SpA, Seregno, Milan, Italy;
resveratrol, K.-W. Pfannenschmidt GMBH, Hamburg, Ger-
many; grape seed oil, G. Balestrini Srl, Milan, Italy; 𝛼-
tocopherol, Van Eeghein Functional Ingredients, Amster-
dam, Netherlands; and Na-selenite, Giusto Faravelli SpA,
Milan, Italy. These compounds/oils were administered alone
or in combination to HaCaT and NCTC 2544 keratinocytes.
Since the present study was performed in vitro on human
keratinocyte lines with the aim to understand the potential
activities of the dietary supplement once consumed in vivo,
we did not use the components in the original concentrations
and ratios of the formulation of the supplement. Instead, we
referred to the concentrations of these components found in
human plasma following their dietary consumption [13–18].
On the basis of these plasmatic concentrations, most of the
authors that previously evaluated in vitro the beneficial effects
of such components on keratinocytes or other cells used the
ranges of concentrations that are reported in Table 1 [19–38].
Since these components, used within these ranges of concen-
tration, had always showed lack of toxicity and ability to effi-
ciently decrease oxidative stress and/or inflammation in vitro,
in the present work concentrations within these ranges were
used. In particular, three concentrations were used for all
the components, according to the increasing quantitative
scheme: 1, 1 × 5, and 5 × 5. The concentrations used are as
follows: 1.2, 6.0, and 30.0𝜇M for 𝛼-T; 0.4, 2.0, and 10.0 𝜇M for
CQ10, LA, and Resv; 0.8, 4.0, and 20.0𝜇g/mL for GO andKO.
Only for Se the concentration scheme used was as follows:
1, 1 × 2.5, and 1 × 5, which corresponded to 0.08, 0.2, and
0.4 𝜇M, in order to avoid the cytotoxicity showed in prelim-
inary experiments by Se concentrations higher than 0.4𝜇M.
In agreement, Hazane-Puch et al. [31] recently reported that
concentrations higher than 1.0 𝜇M of Na-selenite exerted a
cytotoxic effect on HaCaT cells. GO is not reported in Table 1
since, unlike similar oils extracted from fish or krill, it has
never been administered in vitro to cell cultures. So far,
instead, only aqueous extracts from grape seed have been
used in vitro. On this basis, in the present work, GOwas used
at the same concentrations used for KO. A cell viability ≥95%
was observed in preliminary experiments carried out on
HaCaT and NCTC 2544 cells using all the concentrations
reported above.
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Table 1: Compound concentrations reported to inhibit oxidative stress or inflammation or to exert other beneficial effects∗ in keratinocytes
or other cultured cells.
Compounds Concentration ranges Cultured cells Reference
Coenzyme Q10 (CQ10) 0.5–10 𝜇M Keratinocytes fibroblasts [19, 20]
Krill oil (KO) 2.5–20.0 𝜇g/mL Colon cancer cells [21, 22]∗∗
Lipoic acid (LA) 0.01–1mM Keratinocytes, neurons, muscle cells, and bronchial epithelial cells [23–26]
Resveratrol (Resv) 0.5–100 𝜇M Keratinocytes [27–30]
Na-selenite (Se) 0.1–1𝜇M Keratinocytes [31–33]
𝛼-Tocopherol (𝛼-T) 10–580 𝜇M Keratinocytes [34–38]
∗Antiproliferative effects.
∗∗This reference regards other kinds of marine oil (algal oil or fish oil).
2.3. Immunocytochemical Analysis of Cytokeratin-13 (CK-13).
HaCaT and NCTC 2544 cells were trypsinized, resuspended
at the density of 8 × 104 cells/100 𝜇L, and cytocentrifuged by
Cytospin (Shandon). “Superfrost” polarized slides were used.
Slides were air-dried for 30min; then cells were fixed in 4%
paraformaldehyde for 7min and permeabilized in Triton-X
for further 7min. To avoid the unspecific background due
to endogenous peroxidases, slides were exposed to 3% H
2
O
2
for 2min. To inhibit potential endogenous biotin, the Avidin/
Biotin kit (Vector) was used. The slides were then incubated
for 30min at room temperature with the cytokeratin-13 anti-
body (CK-13, clone 1C7, sc-58721, Santa Cruz Biotechnology)
diluted 1 : 50 in primary Antibody Diluent (Phosphate Green,
Scytek Laboratories). Slides were then incubated with the
secondary antibody (10min at room temperature) using the
Ultra-Tek-HRP kit (Antipolyvalent, Scytek Laboratories).
2.4. Reactive Oxygen Species (ROS) Production. HaCaT and
NCTC 2544 cells were seeded in 6-well multiwell plates at the
density of 5 × 105 cells/well. After 24 h, culture medium was
removed and replaced with fresh culture medium containing
or not the different compounds at increasing concentrations.
After 24 h of treatment, cells were washed in phosphate
buffered saline (PBS) and cell culture medium was replaced
with PBS and incubated at 37∘C in the dark in the pre-
sence of the fluorogenic substrate 6-carboxy-2󸀠,7󸀠-dihydro-
dichlorofluorescein diacetate (DCF, 10 𝜇M). Fluorescence
was measured by a plate cytofluorometer (Cytofluor 2300/
2350 Fluorescence Measurement System (Millipore Corp.,
Bedford, MA)) with an excitation wavelength of 485 nm
and an emission wavelength of 530 nm. As a prooxidant
stimulus, 100𝜇MH
2
O
2
was added to thewells and plateswere
incubated at 37∘C for further 15min and fluorescence pro-
ducedwasmeasured again.This concentrationwas used since
it was observed in preliminary experiments that it induced
the maximal prooxidant effect without causing cell necrosis
(data not shown).
2.5. Lipid Peroxidation Analysis. HaCaT and NCTC 2544
keratinocytes were seeded in Petri dishes at the density of 3 ×
105 cells/mL. After 24 h, culture medium was removed and
replacedwith fresh culturemedium containing or not the dif-
ferent compounds given alone or in combination. The ability
of the different compounds to inhibit lipid peroxidation was
analyzed both in basal conditions and in the presence of two
different free radical sources: 2,2󸀠-azobis (2-amidinopropane)
(AAPH, 25mM), which exogenously produces peroxyl radi-
cals by thermal decomposition, and tert-butyl-hydroperoxide
(t-BOOH, 0.25mM), which endogenously produces alkoxyl
radicals through Fenton reaction [3]. After 22 h of treatment,
AAPH or t-BOOH or vehicle alone was added to culture
dishes for further 2 h. Cells were then trypsinized and cen-
trifuged and 5 × 106 cells for each sample were resuspended
in 200𝜇L of PBS. Then, 200𝜇L of 15% trichloroacetic acid
(TCA) in 0.25MHCl and 200 𝜇L of 0.37% thiobarbituric acid
(TBA) in 0.25M HCl were added. Samples were incubated at
90∘C for 20min and then centrifuged (5000 rpm for 5min) in
order to remove cell debris. The final product of lipid peroxi-
dation is malondialdehyde (MDA) which reacts with TBA to
form a coloured productmeasured spectrophotometrically at
535 nm (𝜀𝜆 = 1.56 × 105).
2.6. Monocyte Chemoattractant Protein-1 (MCP-1) and
Interleukin-6 (IL-6) Analysis. HaCaT cells were seeded at the
density of 5× 103 cells/well in 96-wellmultiwell culture plates.
When cells reached confluence, culture medium was remo-
ved and replaced with fresh culture medium containing
the different compounds in the presence or not of the
proinflammatory cytokine tumor necrosis factor-𝛼 (TNF-𝛼,
20 ng/mL). After a 24 h treatment (6 h pretreatment with
TNF-𝛼 and further 18 h treatment with the compounds),
supernatant was collected, centrifuged to remove suspended
cells, and analyzed by immunoenzymatic assay utilizing
commercial ELISA kits (Biolegend, San Diego, CA, USA).
The minimum detectable concentrations of MCP-1 and IL-6
were 3.9 pg/mL and 4.0 pg/mL, respectively.
2.7. Analysis of p65, I𝜅B𝛼, and p-I𝜅B𝛼. Protein expression
was evaluated by Western Blotting analysis. Briefly, after
the indicated treatments, HaCaT cells were trypsinized, cen-
trifuged, and lysed for 30min in ice-cold lysis buffer (150mM
NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% sodium
dodecyl sulphate (SDS), and 50mM Tris, pH 8.0) containing
protease and phosphatase inhibitors (50 KIU/mL aprotinin,
5 𝜇g/mL leupeptin, 100𝜇M phenylmethanesulfonyl fluoride
(PMSF), 1mM Na
3
VO
4
, 10mM NaF, 1 𝜇M pepstatin, and
100 𝜇Mdithiothreitol (DTT)). Samples were then centrifuged
at 14000 rpm for 10min and supernatants were collected.
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Protein concentration in samples was measured through
Bio-Rad method. 80 𝜇g of total proteins was separated in
a 10% acrylamide/bisacrylamide gel and then transferred
on a polyvinylidene difluoride (PVDF) membrane. The
membrane was blocked in nonfat dry milk (5% in PBS
containing 0.05% Tween (TBST) 1X or in bovine serum
albumin (BSA), 3% in TBST 1X, for the expression of p-I𝜅B𝛼)
for 1 h at room temperature and incubated overnight at 4∘C
in the presence of primary antibodies against p65 [(C-20):
sc-372], I𝜅B𝛼 [(H-4): sc-1643], and p-I𝜅B𝛼 [(B-9): sc-8404]
(Santa Cruz Biotechnology, CA, USA). As a loading control,
membranes were reincubated in the presence of a primary
antibody against 𝛼-actinin [(H-2): sc-17829] (Santa Cruz
Biotechnology, CA, USA). Membranes were then washed
in TBST 1X and incubated in the presence of anti-mouse
(1 : 10000, for I𝜅B𝛼, p-I𝜅B𝛼, and 𝛼-actinin) or anti-rabbit
(1 : 20000, for p65) secondary antibodies in TBST 1X for 1 h
at room temperature. Proteins were visualized incubating the
membranes in the reagents for chemiluminescence detection.
Protein quantification was performed by densitometric anal-
ysis.
2.8. Statistical Analysis. Data (expressed as the means ± SE)
were analyzed by either two-tailed unpaired t-test (Figures 1,
4, 5, 7(c), 8(c), and 8(d)) when two groups were compared
or by one-way analysis of variance (ANOVA) followed by
Dunnett’s test when three or more groups were compared
(Figures 2, 3, 6, 7(a), 7(b), 8(a), and 8(b)) (InStat GraphPad
software).
3. Results and Discussion
In the present work the antioxidant and anti-inflammatory
potential of a combined treatment with seven natural com-
pounds/oils (CoQ, LA, Resv, Se, 𝛼-T, GO, and KO) was
evaluated in vitro. These compounds/oils are known for their
ability to reduce oxidative stress and/or inflammation in
keratinocytes and other types of cells (Table 1).The combined
treatment reproduces the formulation of a dietary supple-
ment indicated for the prevention of skin pathologies. Two
different keratinocyte lines (HaCaT and NCTC 2544) show-
ing different degrees of differentiation [11, 12] were used.
In agreement (Figure 1), it was confirmed by immunocyto-
chemistry that whereas 30% of HaCaT cells were positive to
cytokeratin-13 (CK-13), a specific marker of keratinocyte
differentiation [39], only 10% of NCTC 2544 became positive
to CK-13.
3.1. Antioxidant Activities of the Compounds/Oils Alone or
in Combination. The capacity of each component to inhibit
ROS production in the keratinocytes in basal conditions
(Figure 2) or in the presence of a prooxidant (100 𝜇M
H
2
O
2
) (Figure 3) was first examined. Each component was
used within a range of concentrations known to produce
antioxidant or other beneficial effects in normal or can-
cer cells cultured in vitro (Table 1). After 24 h of treat-
ment and in basal conditions (Figure 2), all the com-
ponents analyzed (except for GO in NCTC 2544 cells)
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Figure 1: Cytokeratin-13 (CK-13) basal expression in NCTC 2544
and HaCaT cells. CK-13-positive cells were evaluated by immuno-
cytochemistry and counted under inverted microscopy. Values
represent the means ± SE of CK-13-positive cells counted in 5 and
8 microscopic fields for NCTC 2544 and HaCaT cells, respectively.
∗: significantly different, 𝑃 < 0.0001, two-tailed unpaired 𝑡-test.
significantly reduced ROS production to a comparable
extent in both the cell lines (Figure 2). However, when a
prooxidant agent (100 𝜇M H
2
O
2
, Figure 3) was added to
NCTC 2544 after 24 h, only 𝛼-T and Se were still able to
retain their significant effect at all the concentrations tested
(Figure 3(a)), even though with less efficiency. Both 𝛼-T and
Se at the maximal concentrations inhibited ROS production
by 86% in basal conditions and by 49% and 61% with
H
2
O
2
, respectively. Instead, inHaCaT cells treatedwithH
2
O
2
the inhibitory effect on ROS production was still observed
(Figure 3(b)) with all the components, except for Resv and
KO at the lowest concentrations. However, on the whole, in
the presence of H
2
O
2
, a similar maximal inhibition of about
50% was obtained with all the compounds/oils (excluding
KO) in both the cell lines. Similarly, in basal conditions
the maximal inhibition obtained was similar for all the
compounds (excluding GO in NCTC 2544), being in the
ranges of 75–90% inNCTC 2544 and 60–90% inHaCaT cells.
The inhibitory effect of a combined treatment with all the
compounds/oils on the cellular production of ROS was next
analyzed. When the components were administered in com-
bination at the highest concentrations used, they markedly
and significantly reduced ROS production in NCTC 2544
cells, both in basal conditions (93% reduction, 𝑃 < 0.027),
as well as with H
2
O
2
(57% reduction, 𝑃 < 0.0099). However,
if these effects were compared with those obtained (Figures
2(a) and 3(a)) treating NCTC 2544 cells with 𝛼-T alone, both
in basal conditions, or with H
2
O
2
, no significant difference
was observed. Also in HaCaT cells the combined treatment
caused a strong and significant reduction of ROS production
(86% reduction in basal conditions, 𝑃 < 0.021; 49% with
H
2
O
2
, 𝑃 < 0.0001). Moreover, in the presence of H
2
O
2
,
the reduction was significantly higher than that (30%, 𝑃 <
0.05) observed with 30 𝜇M 𝛼-T alone. However, if the results
obtained in the two cell lines were compared, the inhibitory
effect of the combined treatment was slightly, even if not
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Figure 2: Effect of the seven supplement’s components on ROS production in keratinocytes in basal conditions. Cells were treated for 24 h
with three increasing concentrations of the components administered individually (see Section 2). Data are the means ± SE of a number
of determinations ranging from 3 to 8. a: significantly different from control (𝑃 < 0.05); b: significantly different from control (𝑃 < 0.01),
one-way ANOVA followed by Dunnett’s test.
0
40
80
120
160
NCTC 2544
LA ResvCQ10 KO GOSeC
a
a
a a
b b a b
a
aa
𝛼-T
+H2O2
RO
S 
(fl
uo
re
sc
en
ce
 ar
bi
tr
ar
y 
un
its
)
(a)
0
40
80
120
160
HaCaT
b
b
b
LA ResvCQ10 KO GOSeC
b
b
b b b
a
b b b
a
a
b b
RO
S 
(fl
uo
re
sc
en
ce
 ar
bi
tr
ar
y 
un
its
)
𝛼-T
+H2O2
(b)
Figure 3: Effect of the seven supplement’s components on ROS production in keratinocytes exposed to H
2
O
2
. Cells were treated for 24 h
with three increasing concentrations of the components and then exposed to 100𝜇M H
2
O
2
for 30min. The three concentrations used for
each component are reported in Section 2. Data are the means ± SE of a number of determinations ranging from 3 to 8. a: significantly
different from control (𝑃 < 0.05); b: significantly different from control (𝑃 < 0.01), one-way ANOVA followed by Dunnett’s test.
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Figure 4: Effect of the combined treatment with all the seven supplement’s components on ROS production in keratinocytes exposed or not
to H
2
O
2
. Cells were treated simultaneously for 24 h with all the components and then exposed to H
2
O
2
(100𝜇M, 30min) or vehicle alone.
Each component was used at the highest concentration reported in Section 2. Data are themeans ± SE of a number of determinations ranging
from 3 to 8. Significance was evaluated by the two-tailed unpaired 𝑡-test.
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Figure 5: Effect of the combined treatment with all the seven supplement’s components on lipid peroxidation in keratinocytes exposed or not
to prooxidant agents. Cells were treated simultaneously with all the components for 24 h and then exposed for 1 h to the prooxidant agents
AAPH (25mM) or t-BOOH (0.25mM) or vehicle alone. Each component was used at the highest concentration reported in Section 2. Lipid
peroxidationwas evaluated spectrophotometrically asMDAproduction.Data are themeans± SE of a number of determinations ranging from
3 to 6. ∗: significantly different from respective control (NCTC 2455: CT versus control, 𝑃 < 0.007; CT +AAPH versus AAPH, 𝑃 < 0.0003;
CT +t-BOOH versus t-BOOH, 𝑃 < 0.04; HaCaT: CT versus control, 𝑃 < 0.03; CT +AAPH versus AAPH, 𝑃 < 0.02; CT +t-BOOH versus
t-BOOH, 𝑃 < 0.03, two-tailed unpaired 𝑡-test).
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Figure 6: Effect of 𝛼-T alone or combined with each of the other supplement’s components on lipid peroxidation in keratinocytes exposed or
not to prooxidant agents. Cells were treated with 𝛼-T alone or combined with each of the other supplement’s components for 24 h and then
exposed for 1 h to the prooxidant agents AAPH (25mM) or t-BOOH (0.25mM) or vehicle alone. Each component was used at the highest
concentration reported in Section 2. Lipid peroxidation was evaluated spectrophotometrically as MDA production. Data are the means ± SE
of a number of determinations ranging from 3 to 6. a: significantly different from respective control (𝑃 < 0.05); b: significantly different from
respective control (𝑃 < 0.01), one-way ANOVA followed by Dunnett’s test.
significantly, more evident in the NCTC 2544 cells (93%
versus 86% inhibition in basal conditions and 57%versus 49%
in the presence of H
2
O
2
, in NCTC 2544 and in HaCaT cells,
respectively) (Figure 4).
The ability of the combined treatment to inhibit lipid
peroxidation was also evaluated in NCTC 2544 and HaCaT
cells by assessing MDA production (Figure 5), either in basal
conditions or after a treatment with two different prooxidant
agents with different specificity of action, as follows: AAPH
(25mM) and t-BOOH (0.25mM). The combined treatment
induced a strong and significant reduction of MDA produc-
tion in all the conditions (see legend of Figure 4 for further
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Figure 7: Effect of the seven supplement’s components on HaCaT keratinocyte IL-6 production. Cells were exposed for 18 h to increasing
concentrations of the components in the absence (a) or in the presence (b) of TNF-𝛼 (20 ng/mL, 6 h pretreatment and further 18 h with the
components); the two concentrations used for each component are the lowest and highest concentrations reported in Section 2. Data are the
means ± SE of 4 determinations. a: significantly different from control (𝑃 < 0.05); b: significantly different from control (𝑃 < 0.01), one-way
ANOVA followed by Dunnett’s test. (c) Cells were treated simultaneously with all the components, both in basal conditions or in the presence
of TNF-𝛼 (20 ng/mL), following the timing of the previous experiment. Each component was used at the highest concentration reported in
Section 2. Data are the means ± SE of 4 determinations. ∗: significantly different from respective control (𝑃 < 0.0001, two-tailed unpaired
𝑡-test).
detail on significance values). Moreover, also in this case,
NCTC 2544 cells showed a slightly higher sensitivity than
HaCaT cells to the inhibitory effect of the combined treat-
ment. In particular, the combined treatment reduced MDA
production by 52% versus 36% in NCTC 2544 and in HaCaT
cells, in basal conditions, by 69% versus 49% in the presence
of AAPH, and by 63% versus 46% in the presence of t-
BOOH, respectively.This is an interesting finding, since it has
been reported that differentiated keratinocytes show higher
level of endogenous antioxidants and are more resistant than
the less differentiated cells to prooxidant insults [40, 41]. A
supplementation combining the seven components studied
could therefore have the potential to efficiently prevent the
oxidative injury, even when it affects the less differentiated
cells located in the basal layer of epidermis.
Since in the experimental conditions used 𝛼-T appeared
as one of the compounds showing maximal efficiency in
inhibiting ROS production (Figures 2 and 3), its ability
to inhibit MDA produced in the presence or absence of
AAPH or t-BOOH (Figure 6) was also evaluated. In all the
experimental conditions 𝛼-T was able to significantly inhibit
MDA production with similar efficiencies, both in NCTC
2544 (basal condition, +AAPH, and +t-BOOH: 50%, 58%,
and 61% inhibition, respectively,𝑃 < 0.01) and inHaCaT cells
(basal condition: 45%, 𝑃 < 0.01; +AAPH and t-BOOH:
40% and 34% inhibition, respectively, 𝑃 < 0.05). In
some experimental conditions, the combined treatment was
significantly more efficient than the individual 30 𝜇M 𝛼-T
treatment, such as in NCTC 2544 cells in the presence
of AAPH (combination: 46% inhibition versus 𝛼-T: 34%
inhibition, 𝑃 < 0.05) or in HaCaT cells in the presence of
t-BOOH (combination: 69% inhibition versus 𝛼-T: 58%
inhibition,𝑃 < 0.05). None of the remaining compounds/oils
used at the maximal concentrations was able to improve
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Figure 8: Effect of the seven supplement’s components on HaCaT keratinocyte MCP-1 production. Cells were exposed to increasing
concentrations of the components in the absence (a) or in the presence (b) of TNF-𝛼 (20 ng/mL, 6 h pretreatment and further 18 h with
the components); the two concentrations used for each component are the lowest and highest concentrations reported in Section 2. Data
are the means ± SE of a number of determinations ranging from 4 to 6. a: significantly different from control (𝑃 < 0.05); b: significantly
different from control (𝑃 < 0.01), one-way ANOVA followed by Dunnett’s test. (c) Cells were exposed simultaneously to all the components,
both in basal conditions or in the presence of TNF-𝛼 (20 ng/mL), following the timing of the previous experiment. Each component was
used at the highest concentration reported in Section 2. Data are the means ± SE of a number of determinations ranging from 3 to 6. ∗:
significantly different from respective control (𝑃 < 0.0001, two-tailed unpaired 𝑡-test). (d) The cells were exposed simultaneously to all the
components excluding Se, both in basal conditions or in the presence of TNF-𝛼 (20 ng/mL), following the timing of the previous experiments.
Each component was used at the highest concentration reported in Section 2. Data are themeans ± SE of a number of determinations ranging
from 6 to 8. ∗: significantly different from respective control (𝑃 < 0.0001, two-tailed unpaired t-test).
significantly the inhibitory effect produced by 30 𝜇M 𝛼-T on
lipid peroxidation (Figure 6), in both the cell lines and all
experimental conditions.The same results were obtained also
when the cells were treated with the lowest concentrations
used (data not shown). Overall, these results confirm that𝛼-T
is one of the most powerful natural dietary antioxidants and,
if it is assumed that it remains unaltered before ingestion and
is efficiently absorbed, its presence in a supplementwith other
antioxidants may ensure the maximum antioxidant effect.
3.2. Anti-Inflammatory Activities of the Compounds/Oils
Alone or in Combination. The anti-inflammatory potential of
the components, administered alone or in combination with
HaCaT cells treated or not with the proinflammatory
cytokine TNF-𝛼 (Figures 7 and 8), was next examined and,
in particular, their effect on the production of the proinflam-
matory cytokines MCP-1, IL-6, and interleukin-1𝛽 (IL-1𝛽)
was evaluated. The levels of IL-1𝛽 secreted by HaCaT cells
were too scarce to allow a correct evaluation and its variations
were never significant as compared to the control (data not
shown). On the other hand, the cells produced high levels
of IL-6 and MCP-1, especially when they were stimulated
with TNF-𝛼. Moreover, it was observed (Figure 7) that all
the compounds/oils (excluding LA) evaluated individually
were able to significantly inhibit IL-6 secretion in our experi-
mental conditions, even though only at some concentrations
and in some of the experimental conditions used (see the
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Figure 9: Effect of the combined treatment with all the seven supplement’s components on I𝜅B𝛼 phosphorylation and p65 expression in
HaCaT keratinocytes. Cells were exposed to the combined treatment (CT) in the absence or in the presence of TNF-𝛼 (20 ng/mL) for 5 h. (a)
A representativeWestern Blot of three similar experiments with the corresponding p-I𝜅B𝛼/I𝜅B𝛼 ratio is shown. (b) A representativeWestern
Blot of three similar experiments with the corresponding p65/𝛼-actinin ratio is shown.
significances in the legend of Figure 7). Similarly, MCP-1
production was significantly inhibited by all the compounds
(Figure 8; see significance in the legend of Figure 8).Themost
efficient inhibitor of both IL-6 andMCP-1 production was Se,
especially in cells stimulated with TNF-𝛼 (0.4 𝜇M Se: 93.6%
inhibition of IL-6 production, 𝑃 < 0.01; 99.0% inhibition of
MCP-1 production, 𝑃 < 0.0001). The combined treatment
with all the components (Figures 7(c) and 8(c)) reduced
markedly and significantly the production of both IL-6
and MCP-1 in all the experimental conditions studied. In
particular, IL-6 production was reduced by 55.0% and 75.0%
in basal conditions and after stimulation with TNF-𝛼, respec-
tively (𝑃 < 0.0001) (Figure 7(c)). In the same conditions, the
treatment reduced MCP-1 production by 98.0% and 99.5%,
respectively (𝑃 < 0.0001) (Figure 8(c)), and this effect was
slightly but significantly higher (𝑃 < 0.05) than that observed
with 0.4𝜇M Se administered alone, both in the presence
and in the absence of TNF-𝛼. This finding is interesting,
since MCP-1 is one of the cytokines most expressed by
keratinocytes during inflammation. It should be emphasized,
however, that the combination of compounds/oils cannot
inhibit MCP-1 production much more efficiently than Se,
given the extremely high inhibitory effect exerted by this
compound alone. Se, however, is present in the supplement
studied in the inorganic form of Na-selenite, which shows an
extremely low absorbance index in humans [42, 43]. For this
reason, it may hardly contribute to the expected beneficial
effect of the dietary supplement in vivo. Nevertheless, it
was observed that if the combined treatment was performed
excluding Se, it was still able to significantly decrease MCP-1
production by HaCaT cells both in basal conditions and in
the presence of TNF-𝛼 (Figure 8(d)), even though to a lower
extent (73.5% and 71.6%, respectively). Interestingly, this
inhibition was significantly higher (𝑃 < 0.001) than that
observed exposing the cells to each of its six other compo-
nents, either in the presence (Figure 8(a)) or in the absence
of TNF-𝛼 (Figure 8(b)).
Afterwards, it was investigated if the combination could
regulate the Nuclear Factor-𝜅B (NF-𝜅B) pathway, known to
be involved in the synthesis of proinflammatory cytokines
(Figure 9). In resting conditions, NF-𝜅B is bound to its
inhibitor I𝜅B𝛼 in a nonphosphorylated form in the cytosol.
When, following an inflammatory stimulus such as TNF-
𝛼, I𝜅B𝛼 is phosphorylated and then degraded, NF-𝜅B can
translocate into the nucleus and activate the transcription of
genes encoding proinflammatory cytokines. In agreement,
the phosphorylation of I𝜅B𝛼 (p-I𝜅B𝛼) increased in HaCaT
cells treated with TNF-𝛼. In line with the ability of the
combined treatment to inhibit the production of IL-6 and
MCP-1, it reduced the phosphorylation of I𝜅B𝛼 (Figure 9(a))
in HaCaT cells, both in the presence and in the absence of
TNF-𝛼.Moreover, in the same conditions, it inhibited also the
expression of the NF-𝜅B subunit p65, decreasing the amount
of NF-𝜅B available for cytokine transcription.
4. Conclusions
On the whole, the findings show that the combined treatment
of keratinocytes with the antioxidant/anti-inflammatory
compounds/oils studied possesses high antioxidant activity
that, in specific experimental conditions, was higher than that
observed with the individual administration of the most
powerful components. The combined treatment showed also
powerful anti-inflammatory activities. Particularly, it inhib-
ited more efficiently than all the individual components the
secretion of the proinflammatory cytokine MCP-1, which is
known to attract monocytes in the skin, where it is expressed
at high levels and plays a crucial role in the development of
chronic inflammation. In keeping with this finding, the com-
bination inhibited efficiently the molecular pathway associ-
ated with NF-𝜅B, the main transcription factor involved in
the cellular production of proinflammatory cytokines. On
these bases, it can be hypothesized that the simultaneous
presence of the antioxidant/anti-inflammatory components
in the formulation of a dietary supplement could ensure the
achievement of these beneficial effects also in vivo. Moreover,
the development of a formulation for topical use containing
the combination of compounds/oils described could also
be advisable. In fact, this route of administration could
10 BioMed Research International
overcome all the problems related to biodistribution and
metabolic conversion and directly target keratinocytes.
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